
Ocugen, Inc. (NASDAQ:OCGN) shares traded higher on Monday after the company announced a licensing agreement with Kwangdong Pharmaceutical for the exclusive Korean rights to OCU400.
OCGN shares are powering higher on strong volume. Find out why here.

Ocugen, Inc. (NASDAQ:OCGN) shares traded higher on Monday after the company announced a licensing agreement with Kwangdong Pharmaceutical for the exclusive Korean rights to OCU400.
OCGN shares are powering higher on strong volume. Find out why here.